<p>杜比实验室（NYSE:DLB - 获取免费报告）在周五的午盘交易中股价创下 52 周新低。该公司股价最低达到 57.05 美元，最后交易价格为 56.26 美元，成交量为 99714 股。该股票此前收盘价为 64.14 美元。</p>
<p>获取 <strong>杜比实验室</strong> 的提醒：</p>
<h2>影响杜比实验室的关键故事</h2>
<ul>
<li>大屏幕股票因强劲的第二季度财报而飙升</li>
</ul>
<p>以下是本周影响杜比实验室的关键新闻：</p>
<ul>
<li>积极情绪：第二季度业绩超出市场预期——收入同比增长约 7%，达到约 3.956 亿美元，且每股收益超出预期，得益于许可强劲、广播需求旺盛和杜比 Atmos 的广泛采用。杜比第二季度业绩因许可强劲而超出预期，收入同比增长。</li>
<li>中性情绪：公司宣布每季度派发 0.36 美元的股息（除息日为 5 月 12 日，支付日为 5 月 20 日），意味着约 2.5% 的收益率——对收入投资者有支持作用，但相较于增长驱动因素则显得温和。</li>
<li>中性情绪：电话会议/会议记录和新闻稿提供了管理层的评论；投资者可以深入了解产品采用和市场组合的相关言论。杜比实验室（DLB）2026 年第二季度财报电话会议记录。</li>
<li>消极情绪：短期指引令人失望——管理层给出的第三季度每股收益预期为 0.56–0.71 美元，收入预期为 2.95 亿–3.25 亿美元，低于华尔街预测（市场共识约为 0.92 美元每股收益和约 3.43 亿美元收入）。这一疲软的短期展望是股价下跌的主要原因。</li>
<li>消极情绪：现金流和资产负债表项目引起关注：第三方报告指出，运营现金流同比大幅下降，现金余额减少，以及显著的内部人士抛售——这些因素在指引疲软时可能加剧下行风险。杜比实验室（DLB）股票因 2026 年第二季度财报下跌。</li>
</ul>
<h2>华尔街分析师观点</h2>
<p>DLB 成为多份研究报告的主题。Rosenblatt Securities 在 1 月 30 日的研究报告中重申了 “买入” 评级，并对杜比实验室的股票设定了 85.00 美元的目标价。Wall Street Zen 在 1 月 31 日的研究报告中将杜比实验室的股票评级从 “买入” 下调至 “持有”。Barrington Research 在周一重申了 “跑赢大盘” 评级，并设定了 90.00 美元的目标价。最后，Weiss Ratings 在 3 月 27 日的报告中重新发布了对杜比实验室股票的 “持有（c-）” 评级。三位股票研究分析师给予该股票 “买入” 评级，两位分析师给予该公司股票 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 90.75 美元。</p>
<p><strong>获取我们对 DLB 的最新分析</strong></p>
<h2>杜比实验室股票表现</h2>
<p>该股票市值为 53.9 亿美元，市盈率为 22.80，贝塔值为 0.86。该公司的 50 日移动平均线为 62.58 美元，200 日移动平均线为 64.55 美元。</p>
<p>杜比实验室（NYSE:DLB - 获取免费报告）最近于 1 月 29 日发布了季度财报。该电子产品制造商报告季度每股收益为 1.06 美元，超出市场共识预期的 0.99 美元，超出 0.07 美元。杜比实验室的股本回报率为 11.50%，净利润率为 17.97%。该公司在本季度的收入为 3.4671 亿美元，而分析师预期为 3.4126 亿美元。在去年同期，该公司每股收益为 1.14 美元。本季度的收入较去年同期下降了 2.8%。整体来看，分析师预计杜比实验室在当前财政年度将发布 3.17 美元的每股收益。</p>
<h2>杜比实验室宣布分红</h2>
<p>该公司最近还宣布了季度分红，将于 5 月 20 日（星期三）支付。5 月 12 日（星期二）登记的股东将获得每股 0.36 美元的分红。这代表着每年 1.44 美元的分红和 2.6% 的收益率。该分红的除息日为 5 月 12 日（星期二）。杜比实验室的派息比率目前为 58.06%。</p>
<h2>内部人士买卖</h2>
<p>在相关消息中，SVP Shriram Revankar 在 2 月 17 日（星期二）出售了 3000 股公司的股票。该股票以平均价格 66.14 美元出售，总价值为 198,420.00 美元。交易后，该高级副总裁直接持有公司股票 83,218 股，价值 5,504,038.52 美元。这代表着其持股减少了 3.48%。该交易已在证券交易委员会的法律文件中披露，相关信息可在此链接查看。此外，CAO Ryan Nicholson 在 2 月 13 日（星期五）出售了 2667 股公司的股票。该股票以平均价格 66.38 美元出售，总价值为 177,035.46 美元。交易完成后，首席会计官持有公司股票 36,956 股，价值 2,453,139.28 美元。该交易代表着其持股减少了 6.73%。该交易的披露信息可在 SEC 文件中查看。公司内部人士持有公司股票的 37.93%。</p>
<h2>机构资金流入和流出</h2>
<p>几家机构投资者最近调整了对该公司的持股。Ashton Thomas Private Wealth LLC 在第三季度购买了价值约 615,000 美元的 Dolby Laboratories 新股份。摩根大通在第三季度将其在 Dolby Laboratories 的持股增加了 81.3%。摩根大通目前拥有 312,028 股该电子制造商的股票，价值 22,582,000 美元，此前在上个季度又购买了 139,900 股。Alps Advisors Inc. 在第三季度将其在 Dolby Laboratories 的持股增加了 6.7%。Alps Advisors Inc. 目前拥有 281,532 股该电子制造商的股票，价值 20,374,000 美元，此前在此期间又购买了 17,592 股。Meeder Asset Management Inc. 在第三季度将其在 Dolby Laboratories 的持股增加了 787.1%。Meeder Asset Management Inc. 目前拥有 27,526 股该电子制造商的股票，估值为 1,992,000 美元，此前在上个季度又购买了 24,423 股。最后，Summit Creek Advisors LLC 在第三季度将其在 Dolby Laboratories 的持股增加了 24.9%。Summit Creek Advisors LLC 目前拥有 125,034 股该电子制造商的股票，估值为 9,049,000 美元，此前在此期间又购买了 24,905 股。目前 58.56% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Dolby Laboratories 公司简介</h2>
<p>(获取免费报告)</p>
<p>Dolby Laboratories, Inc 是全球音频和影像技术的领导者，专注于开发、许可和部署增强娱乐和通信体验的解决方案。公司的核心业务围绕创建先进的音频编解码器、降噪系统和空间音效技术，适用于包括电影院、广播、游戏、流媒体和个人设备在内的广泛应用。Dolby 的许可模式使消费电子制造商、内容创作者和服务提供商能够将其技术集成到电视、智能手机、家庭影院系统和机顶盒等产品中。</p>
<p>其旗舰创新包括 Dolby Atmos，这是一种沉浸式音频格式，为影院和家庭系统提供三维音效；Dolby Digital 和 Dolby Digital Plus，这些是广泛采用的广播和流媒体音频压缩格式；以及 Dolby Vision，这是一种高动态范围成像技术，扩展了显示器的色彩、对比度和亮度。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比 Dolby Laboratories 更好的股票</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Dolby Laboratories 吗？</h2>
<p>在你考虑投资 Dolby Laboratories 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Dolby Laboratories 并不在名单上。</p>
<p>虽然 Dolby Laboratories 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

杜比实验室

<p>杜比实验室 (NYSE:DLB) 的股票在 $56.26 达到新的 52 周低点，较之前的收盘价 $64.14 下跌。此次下跌是由于第三季度指引令人失望，预计每股收益在 $0.56 至 $0.71 之间，低于分析师的预期。尽管第二季度的财报表现积极，但由于运营现金流下降和内部人士抛售，股票表现受到影响。分析师维持 “适度买入” 评级，普遍目标价为 $90.75。公司还宣布季度股息为 $0.36，收益率约为 2.6%</p>

<p>Dolby Laboratories (NYSE:DLB - Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The company traded as low as $57.05 and last traded at $56.26, with a volume of 99714 shares traded. The stock had previously closed at $64.14.</p>
<div class="lb-trans"><p>杜比实验室（NYSE:DLB - 获取免费报告）在周五的午盘交易中股价创下 52 周新低。该公司股价最低达到 57.05 美元，最后交易价格为 56.26 美元，成交量为 99714 股。该股票此前收盘价为 64.14 美元。</p>
</div><p>Get <strong>Dolby Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>杜比实验室</strong> 的提醒：</p>
</div><h2>Key Stories Impacting Dolby Laboratories</h2>
<div class="lb-trans"><h2>影响杜比实验室的关键故事</h2>
</div><ul>
<li>Big Screen Stock Soars on Blockbuster Q2 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>大屏幕股票因强劲的第二季度财报而飙升</li>
</ul>
</div><p>Here are the key news stories impacting Dolby Laboratories this week:</p>
<div class="lb-trans"><p>以下是本周影响杜比实验室的关键新闻：</p>
</div><ul>
<li>Positive Sentiment: Q2 results beat consensus — revenue rose ~7% YoY to ~$395.6M and EPS topped estimates, driven by licensing strength, strong broadcast demand and expanding Dolby Atmos adoption. Dolby Q2 Earnings Top Estimates on Licensing Strength, Revenues Up Y/Y</li>
<li>Neutral Sentiment: Company announced a $0.36 quarterly dividend (ex‑dividend May 12, payable May 20), implying a ~2.5% yield — supportive for income investors but modest vs. growth drivers.</li>
<li>Neutral Sentiment: Conference call / transcript and press release provide management commentary; investors can dig into remarks on product adoption and market mix for color. Dolby Laboratories, Inc. (DLB) Q2 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: Near‑term guidance disappointed — management gave Q3 EPS of $0.56–$0.71 and revenue guidance of $295M–$325M, below Street forecasts (consensus ~ $0.92 EPS and ~$343M revenue). That soft short‑term outlook is the main driver of the stock decline.</li>
<li>Negative Sentiment: Cash‑flow and balance‑sheet items drew attention: third‑party reporting flagged substantially lower operating cash flow year‑over‑year, a dip in cash balances, and notable insider selling — factors that can amplify downside when guidance is weak. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：第二季度业绩超出市场预期——收入同比增长约 7%，达到约 3.956 亿美元，且每股收益超出预期，得益于许可强劲、广播需求旺盛和杜比 Atmos 的广泛采用。杜比第二季度业绩因许可强劲而超出预期，收入同比增长。</li>
<li>中性情绪：公司宣布每季度派发 0.36 美元的股息（除息日为 5 月 12 日，支付日为 5 月 20 日），意味着约 2.5% 的收益率——对收入投资者有支持作用，但相较于增长驱动因素则显得温和。</li>
<li>中性情绪：电话会议/会议记录和新闻稿提供了管理层的评论；投资者可以深入了解产品采用和市场组合的相关言论。杜比实验室（DLB）2026 年第二季度财报电话会议记录。</li>
<li>消极情绪：短期指引令人失望——管理层给出的第三季度每股收益预期为 0.56–0.71 美元，收入预期为 2.95 亿–3.25 亿美元，低于华尔街预测（市场共识约为 0.92 美元每股收益和约 3.43 亿美元收入）。这一疲软的短期展望是股价下跌的主要原因。</li>
<li>消极情绪：现金流和资产负债表项目引起关注：第三方报告指出，运营现金流同比大幅下降，现金余额减少，以及显著的内部人士抛售——这些因素在指引疲软时可能加剧下行风险。杜比实验室（DLB）股票因 2026 年第二季度财报下跌。</li>
</ul>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>DLB has been the subject of a number of research reports. Rosenblatt Securities reaffirmed a &#34;buy&#34; rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, January 30th. Wall Street Zen cut shares of Dolby Laboratories from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, January 31st. Barrington Research reiterated an &#34;outperform&#34; rating and set a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday. Finally, Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Dolby Laboratories in a report on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $90.75.</p>
<div class="lb-trans"><p>DLB 成为多份研究报告的主题。Rosenblatt Securities 在 1 月 30 日的研究报告中重申了 “买入” 评级，并对杜比实验室的股票设定了 85.00 美元的目标价。Wall Street Zen 在 1 月 31 日的研究报告中将杜比实验室的股票评级从 “买入” 下调至 “持有”。Barrington Research 在周一重申了 “跑赢大盘” 评级，并设定了 90.00 美元的目标价。最后，Weiss Ratings 在 3 月 27 日的报告中重新发布了对杜比实验室股票的 “持有（c-）” 评级。三位股票研究分析师给予该股票 “买入” 评级，两位分析师给予该公司股票 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 90.75 美元。</p>
</div><p><strong>Get Our Latest Analysis on DLB</strong></p>
<div class="lb-trans"><p><strong>获取我们对 DLB 的最新分析</strong></p>
</div><h2>Dolby Laboratories Stock Performance</h2>
<div class="lb-trans"><h2>杜比实验室股票表现</h2>
</div><p>The stock has a market cap of $5.39 billion, a P/E ratio of 22.80 and a beta of 0.86. The firm's 50 day moving average is $62.58 and its 200 day moving average is $64.55.</p>
<div class="lb-trans"><p>该股票市值为 53.9 亿美元，市盈率为 22.80，贝塔值为 0.86。该公司的 50 日移动平均线为 62.58 美元，200 日移动平均线为 64.55 美元。</p>
</div><p>Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings data on Thursday, January 29th. The electronics maker reported $1.06 EPS for the quarter, beating the consensus estimate of $0.99 by $0.07. Dolby Laboratories had a return on equity of 11.50% and a net margin of 17.97%.The firm had revenue of $346.71 million during the quarter, compared to analyst estimates of $341.26 million. During the same quarter in the prior year, the business posted $1.14 EPS. The business's revenue for the quarter was down 2.8% compared to the same quarter last year. As a group, analysts expect that Dolby Laboratories will post 3.17 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>杜比实验室（NYSE:DLB - 获取免费报告）最近于 1 月 29 日发布了季度财报。该电子产品制造商报告季度每股收益为 1.06 美元，超出市场共识预期的 0.99 美元，超出 0.07 美元。杜比实验室的股本回报率为 11.50%，净利润率为 17.97%。该公司在本季度的收入为 3.4671 亿美元，而分析师预期为 3.4126 亿美元。在去年同期，该公司每股收益为 1.14 美元。本季度的收入较去年同期下降了 2.8%。整体来看，分析师预计杜比实验室在当前财政年度将发布 3.17 美元的每股收益。</p>
</div><h2>Dolby Laboratories Announces Dividend</h2>
<div class="lb-trans"><h2>杜比实验室宣布分红</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories's payout ratio is currently 58.06%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，将于 5 月 20 日（星期三）支付。5 月 12 日（星期二）登记的股东将获得每股 0.36 美元的分红。这代表着每年 1.44 美元的分红和 2.6% 的收益率。该分红的除息日为 5 月 12 日（星期二）。杜比实验室的派息比率目前为 58.06%。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人士买卖</h2>
</div><p>In related news, SVP Shriram Revankar sold 3,000 shares of the company's stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total value of $198,420.00. Following the transaction, the senior vice president directly owned 83,218 shares of the company's stock, valued at $5,504,038.52. This represents a 3.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, CAO Ryan Nicholson sold 2,667 shares of the firm's stock in a transaction on Friday, February 13th. The stock was sold at an average price of $66.38, for a total value of $177,035.46. Following the completion of the transaction, the chief accounting officer owned 36,956 shares of the company's stock, valued at $2,453,139.28. This trade represents a 6.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 37.93% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，SVP Shriram Revankar 在 2 月 17 日（星期二）出售了 3000 股公司的股票。该股票以平均价格 66.14 美元出售，总价值为 198,420.00 美元。交易后，该高级副总裁直接持有公司股票 83,218 股，价值 5,504,038.52 美元。这代表着其持股减少了 3.48%。该交易已在证券交易委员会的法律文件中披露，相关信息可在此链接查看。此外，CAO Ryan Nicholson 在 2 月 13 日（星期五）出售了 2667 股公司的股票。该股票以平均价格 66.38 美元出售，总价值为 177,035.46 美元。交易完成后，首席会计官持有公司股票 36,956 股，价值 2,453,139.28 美元。该交易代表着其持股减少了 6.73%。该交易的披露信息可在 SEC 文件中查看。公司内部人士持有公司股票的 37.93%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several institutional investors have recently modified their holdings of the company. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Dolby Laboratories in the third quarter worth about $615,000. JPMorgan Chase &amp; Co. boosted its position in Dolby Laboratories by 81.3% in the 3rd quarter. JPMorgan Chase &amp; Co. now owns 312,028 shares of the electronics maker's stock worth $22,582,000 after purchasing an additional 139,900 shares in the last quarter. Alps Advisors Inc. grew its stake in shares of Dolby Laboratories by 6.7% during the 3rd quarter. Alps Advisors Inc. now owns 281,532 shares of the electronics maker's stock worth $20,374,000 after purchasing an additional 17,592 shares during the period. Meeder Asset Management Inc. increased its holdings in shares of Dolby Laboratories by 787.1% during the 3rd quarter. Meeder Asset Management Inc. now owns 27,526 shares of the electronics maker's stock valued at $1,992,000 after purchasing an additional 24,423 shares in the last quarter. Finally, Summit Creek Advisors LLC lifted its stake in shares of Dolby Laboratories by 24.9% in the 3rd quarter. Summit Creek Advisors LLC now owns 125,034 shares of the electronics maker's stock valued at $9,049,000 after purchasing an additional 24,905 shares during the period. 58.56% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家机构投资者最近调整了对该公司的持股。Ashton Thomas Private Wealth LLC 在第三季度购买了价值约 615,000 美元的 Dolby Laboratories 新股份。摩根大通在第三季度将其在 Dolby Laboratories 的持股增加了 81.3%。摩根大通目前拥有 312,028 股该电子制造商的股票，价值 22,582,000 美元，此前在上个季度又购买了 139,900 股。Alps Advisors Inc. 在第三季度将其在 Dolby Laboratories 的持股增加了 6.7%。Alps Advisors Inc. 目前拥有 281,532 股该电子制造商的股票，价值 20,374,000 美元，此前在此期间又购买了 17,592 股。Meeder Asset Management Inc. 在第三季度将其在 Dolby Laboratories 的持股增加了 787.1%。Meeder Asset Management Inc. 目前拥有 27,526 股该电子制造商的股票，估值为 1,992,000 美元，此前在上个季度又购买了 24,423 股。最后，Summit Creek Advisors LLC 在第三季度将其在 Dolby Laboratories 的持股增加了 24.9%。Summit Creek Advisors LLC 目前拥有 125,034 股该电子制造商的股票，估值为 9,049,000 美元，此前在此期间又购买了 24,905 股。目前 58.56% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Dolby Laboratories Company Profile</h2>
<div class="lb-trans"><h2>Dolby Laboratories 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.</p>
<div class="lb-trans"><p>Dolby Laboratories, Inc 是全球音频和影像技术的领导者，专注于开发、许可和部署增强娱乐和通信体验的解决方案。公司的核心业务围绕创建先进的音频编解码器、降噪系统和空间音效技术，适用于包括电影院、广播、游戏、流媒体和个人设备在内的广泛应用。Dolby 的许可模式使消费电子制造商、内容创作者和服务提供商能够将其技术集成到电视、智能手机、家庭影院系统和机顶盒等产品中。</p>
</div><p>Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.</p>
<div class="lb-trans"><p>其旗舰创新包括 Dolby Atmos，这是一种沉浸式音频格式，为影院和家庭系统提供三维音效；Dolby Digital 和 Dolby Digital Plus，这些是广泛采用的广播和流媒体音频压缩格式；以及 Dolby Vision，这是一种高动态范围成像技术，扩展了显示器的色彩、对比度和亮度。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Dolby Laboratories</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Dolby Laboratories 更好的股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Dolby Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Dolby Laboratories 吗？</h2>
</div><p>Before you consider Dolby Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑投资 Dolby Laboratories 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Dolby Laboratories 并不在名单上。</p>
</div><p>While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Dolby Laboratories 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

杜比实验室（NYSE:DLB）创下 1 年新低 - 现在是卖出的时候吗？